HepQuant

HepQuant is a privately held company with unique, patented, and patent-pending technologies for evaluating the liver in patients with chronic liver disease. The company’s products are investigational drug/diagnostic device combinations that have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for commercial sale. They are currently available for investigational use through the FDA IDE application process.